Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Angiogenesis
Published in: Angiogenesis 3/2005

01-12-2005

EDB fibronectin and angiogenesis – a novel mechanistic pathway

Authors: Zia A. Khan, Bosco M. Chan, Shashi Uniyal, Yousef P. Barbin, Hana Farhangkhoee, Shali Chen, Subrata Chakrabarti

Published in: Angiogenesis | Issue 3/2005

Login to get access
Metadata
Title
EDB fibronectin and angiogenesis – a novel mechanistic pathway
Authors
Zia A. Khan
Bosco M. Chan
Shashi Uniyal
Yousef P. Barbin
Hana Farhangkhoee
Shali Chen
Subrata Chakrabarti
Publication date
01-12-2005
Publisher
Springer Netherlands
Published in
Angiogenesis / Issue 3/2005
Print ISSN: 0969-6970
Electronic ISSN: 1573-7209
DOI
https://doi.org/10.1007/s10456-005-9017-6

Other articles of this Issue 3/2005

Angiogenesis 3/2005 Go to the issue

OriginalPaper

Introduction

Review

Angiogenesis in ischaemic and hypertrophic hearts induced by long-term bradycardia

Review

Angiogenesis during exercise and training

OriginalPaper

The inhibition of angiogenesis by antisense oligonucleotides to clusterin

Review

Angiogenesis in the human heart: Gene and cell therapy

OriginalPaper

Autocrine vascular endothelial growth factor signalling in breast cancer. Evidence from cell lines and primary breast cancer cultures in vitro
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine
Image Credits